Arecor Therapeutics plc (LON:AREC – Get Free Report)’s share price dropped 1.8% on Wednesday . The company traded as low as GBX 133.35 ($1.68) and last traded at GBX 135 ($1.70). 6,494 shares traded hands during trading, a decline of 50% from the average daily volume of 12,973 shares. The stock had previously closed at GBX 137.50 ($1.73).
Arecor Therapeutics Price Performance
The stock’s fifty day simple moving average is GBX 137.75 and its 200-day simple moving average is GBX 162.51. The company has a market capitalization of £41.70 million, a P/E ratio of -435.48 and a beta of -0.22. The company has a debt-to-equity ratio of 1.26, a current ratio of 2.52 and a quick ratio of 6.24.
About Arecor Therapeutics
Arecor Therapeutics plc, a biopharmaceutical company, focuses on developing products in diabetes and other indications. The company through its proprietary formulation technology platform, Arestat, developing a portfolio of proprietary products in diabetes and other indications, as well as working with pharmaceutical and biotechnology companies to deliver enhanced reformulations of therapeutic products.
Featured Articles
- Five stocks we like better than Arecor Therapeutics
- What is the Dogs of the Dow Strategy? Overview and Examples
- Lucid’s Stock Price is Still in Reverse: New Lows Are Coming
- Investing in Commodities: What Are They? How to Invest in Them
- Generac Powers Ahead on the Electrification Mega-Trend
- Stock Splits, Do They Really Impact Investors?
- PulteGroup Wins and Wins More on Interest Rate Cuts
Receive News & Ratings for Arecor Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arecor Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
